Christopher Porter

Finished

A structure-based design approach to maximising targeting interactions

Porter, C., Johnston, A., Scanlon, M. & Owen, D. J.

1/07/20 → 31/12/23

Project: Research

LCSRIF: Live Cell Super Resolution Imaging Facility

Caruso, F., Porter, C., Pouton, C., Johnston, A., Yeo, L. Y., Cavalieri, F., Yarovsky, I., Kent, S., Cortez-Jugo, C., O'Brien-Simpson, N. M., Hinde, E., Yeo, L. Y. & Wise, A.

25/06/20 → 24/06/21

Project: Research

Developing new tools for chemical biology

Scanlon, M., Porter, C., Halls, M. & Doak, B.

1/01/20 → 31/12/22

Project: Research

Intracellular Drug Transport

Porter, C., Scanlon, M. & Halls, M.

26/04/18 → 26/04/20

Project: Research

Maximising Stability of Novel Lipophilic Salts in Lipid Formulations

Porter, C., Williams, H. & Tangso, K.

Lonza (Australia)

1/07/17 → 1/08/18

Project: Research

Protein engineering approaches to next generation targeting agents

Porter, C., Johnston, A., Owen, D. J. & Yuen, D.

1/04/17 → 31/03/20

Project: Research

Designing Dendrimer Based Nanomedicines

Porter, C., Owen, D. J. & Noi, L.

1/04/17 → 31/03/20

Project: Research

Anti-metastasis therapy via nanoparticle mediated drug delivery

Anderson, R. L., Porter, C. & Johnston, A.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/17 → 31/12/20

Project: Research

A Safe, Orally Administered Agent for Dengue

Jans, D., Charman, S., Dow, G., Low, J., Porter, C., Vasudevan, S. & Wagstaff, K.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/17 → 31/12/19

Project: Research

BASI Culex Automatic animal sampling equipment GNT9000389

Trevaskis, N., Porter, C., McIntosh, M. & Pouton, C.

1/12/16 → 31/12/17

Project: Research

Drug targeting to sites of lymph-adipose interaction to transform the treatment of disease

Trevaskis, N., Porter, C., Watt, M. & Creek, D.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/16 → 31/12/18

Project: Research

Perturbation of the extracellular architecture to promote the absorption and lymphatic transport of biologicalmacromolecules

Porter, C., Kaminskas, L., Landersdorfer, C., McIntosh, M. & Keller, G.

Australian Research Council (ARC), Halozyme Therapeutics Inc

6/01/15 → 31/12/18

Project: Research

Understanding the Cellular Pathways of Nuclear Receptor Activation

Porter, C., Bunnett, N., Halls, M. & Scanlon, M.

Australian Research Council (ARC), Monash University

1/01/15 → 31/12/19

Project: Research

The Importance of Receptor Trafficking for Signalling of Pain and Inflammation

Halls, M., Bunnett, N., Canals, M., Davis, T. & Porter, C.

National Health and Medical Research Council (NHMRC) (Australia)

1/01/15 → 31/12/19

Project: Research

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology

Davis, T., Boyd, B., Bunnett, N., Porter, C., Caruso, F., Kent, S., Thordarson, P., Kearnes, M., Gooding, J., Kavallaris, M., Thurecht, K., Whittaker, A. K., Parton, R., Corrie, S. R., Johnston, A., McGhee, J., Greguric, I. D., Stevens, M. M., Lewis, J. S., Lee, D. S., Alexander, C., Dawson, K., Hawker, C., Haddleton, D., Thierry, B., Prestidge, C. A., Meyer, A., Jones-Jayasinghe, N., Voelcker, N., Nann, T. & McLean, K.

Australian Research Council (ARC), Monash University, University of Melbourne, University of New South Wales (UNSW), University of Queensland , University of South Australia, Monash University – Internal Faculty Contribution, University of Wisconsin Madison, Memorial Sloan Kettering Cancer Center, University of California System, University College Dublin, Imperial College London, University of Warwick, Sungkyunkwan University, Australian Nuclear Science and Technology Organisation (ANSTO) , University of Nottingham